AMGEN INC (1AMGN.MI) Stock Fundamental Analysis
Europe - BIT:1AMGN - US0311621009 - Common Stock
253.8 EUR
-2.75 (-1.07%)
We assign a fundamental rating of 5 out of 10 to 1AMGN. 1AMGN was compared to 76 industry peers in the Biotechnology industry. 1AMGN has an excellent profitability rating, but there are concerns on its financial health. 1AMGN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year 1AMGN was profitable.
1AMGN had a positive operating cash flow in the past year.
1AMGN had positive earnings in each of the past 5 years.
1AMGN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
1AMGN's Return On Assets of 7.53% is amongst the best of the industry. 1AMGN outperforms 85.33% of its industry peers.
1AMGN's Return On Equity of 89.11% is amongst the best of the industry. 1AMGN outperforms 100.00% of its industry peers.
1AMGN has a better Return On Invested Capital (14.12%) than 90.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1AMGN is in line with the industry average of 13.32%.
The 3 year average ROIC (13.04%) for 1AMGN is below the current ROIC(14.12%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.53% | ||
| ROE | 89.11% | ||
| ROIC | 14.12% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
1.3 Margins
1AMGN has a better Profit Margin (18.96%) than 86.67% of its industry peers.
In the last couple of years the Profit Margin of 1AMGN has declined.
The Operating Margin of 1AMGN (31.30%) is better than 90.67% of its industry peers.
1AMGN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 69.71%, 1AMGN is in the better half of the industry, outperforming 65.33% of the companies in the same industry.
1AMGN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.3% | ||
| PM (TTM) | 18.96% | ||
| GM | 69.71% |
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
2. Health
2.1 Basic Checks
1AMGN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, 1AMGN has more shares outstanding
Compared to 5 years ago, 1AMGN has less shares outstanding
The debt/assets ratio for 1AMGN has been reduced compared to a year ago.
2.2 Solvency
The Debt to FCF ratio of 1AMGN is 4.94, which is a neutral value as it means it would take 1AMGN, 4.94 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 4.94, 1AMGN belongs to the best of the industry, outperforming 81.33% of the companies in the same industry.
1AMGN has a Debt/Equity ratio of 7.24. This is a high value indicating a heavy dependency on external financing.
1AMGN has a Debt to Equity ratio of 7.24. This is in the lower half of the industry: 1AMGN underperforms 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.24 | ||
| Debt/FCF | 4.94 | ||
| Altman-Z | N/A |
ROIC/WACC1.5
WACC9.43%
2.3 Liquidity
1AMGN has a Current Ratio of 1.31. This is a normal value and indicates that 1AMGN is financially healthy and should not expect problems in meeting its short term obligations.
1AMGN has a Current ratio of 1.31. This is in the lower half of the industry: 1AMGN underperforms 66.67% of its industry peers.
1AMGN has a Quick Ratio of 1.31. This is a bad value and indicates that 1AMGN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of 1AMGN (0.98) is worse than 69.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.31 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 17.26% over the past year.
Measured over the past 5 years, 1AMGN shows a small growth in Earnings Per Share. The EPS has been growing by 5.97% on average per year.
1AMGN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.88%.
Measured over the past years, 1AMGN shows a small growth in Revenue. The Revenue has been growing by 7.43% on average per year.
EPS 1Y (TTM)17.26%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%21.13%
Revenue 1Y (TTM)12.88%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%9.43%
3.2 Future
Based on estimates for the next years, 1AMGN will show a small growth in Earnings Per Share. The EPS will grow by 4.13% on average per year.
The Revenue is expected to grow by 3.12% on average over the next years.
EPS Next Y8.45%
EPS Next 2Y5.44%
EPS Next 3Y4.87%
EPS Next 5Y4.13%
Revenue Next Year7.54%
Revenue Next 2Y4.58%
Revenue Next 3Y3.91%
Revenue Next 5Y3.12%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
1AMGN is valuated correctly with a Price/Earnings ratio of 13.46.
Based on the Price/Earnings ratio, 1AMGN is valued cheaper than 89.33% of the companies in the same industry.
When comparing the Price/Earnings ratio of 1AMGN to the average of the S&P500 Index (26.91), we can say 1AMGN is valued slightly cheaper.
A Price/Forward Earnings ratio of 13.32 indicates a correct valuation of 1AMGN.
Based on the Price/Forward Earnings ratio, 1AMGN is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.92. 1AMGN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.46 | ||
| Fwd PE | 13.32 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1AMGN is valued cheaper than 82.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1AMGN is valued cheaply inside the industry as 90.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.88 | ||
| EV/EBITDA | 12.48 |
4.3 Compensation for Growth
1AMGN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1AMGN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.59
PEG (5Y)2.25
EPS Next 2Y5.44%
EPS Next 3Y4.87%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.22%, 1AMGN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 8.16, 1AMGN pays a better dividend. On top of this 1AMGN pays more dividend than 97.33% of the companies listed in the same industry.
1AMGN's Dividend Yield is a higher than the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.22% |
5.2 History
The dividend of 1AMGN is nicely growing with an annual growth rate of 9.41%!
Dividend Growth(5Y)9.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
36.49% of the earnings are spent on dividend by 1AMGN. This is a low number and sustainable payout ratio.
1AMGN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP36.49%
EPS Next 2Y5.44%
EPS Next 3Y4.87%
BIT:1AMGN (10/3/2025, 7:00:00 PM)
253.8
-2.75 (-1.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners84.15%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap136.64B
Revenue(TTM)34.92B
Net Income(TTM)6.62B
Analysts72
Price Target274.32 (8.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.22% |
Yearly Dividend7.79
Dividend Growth(5Y)9.41%
DP36.49%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.69%
Min EPS beat(2)11.64%
Max EPS beat(2)11.73%
EPS beat(4)4
Avg EPS beat(4)8.21%
Min EPS beat(4)2.49%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)4.35%
EPS beat(12)10
Avg EPS beat(12)3.9%
EPS beat(16)14
Avg EPS beat(16)4.02%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.84%
Max Revenue beat(2)0.68%
Revenue beat(4)2
Avg Revenue beat(4)-0.49%
Min Revenue beat(4)-2.15%
Max Revenue beat(4)0.68%
Revenue beat(8)2
Avg Revenue beat(8)-1.11%
Revenue beat(12)3
Avg Revenue beat(12)-0.9%
Revenue beat(16)4
Avg Revenue beat(16)-0.92%
PT rev (1m)-2.09%
PT rev (3m)-2.09%
EPS NQ rev (1m)-6.26%
EPS NQ rev (3m)-6.26%
EPS NY rev (1m)1.2%
EPS NY rev (3m)1.2%
Revenue NQ rev (1m)0.71%
Revenue NQ rev (3m)0.71%
Revenue NY rev (1m)1.12%
Revenue NY rev (3m)1.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.46 | ||
| Fwd PE | 13.32 | ||
| P/S | 4.53 | ||
| P/FCF | 13.88 | ||
| P/OCF | 13.16 | ||
| P/B | 21.28 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.48 |
EPS(TTM)18.85
EY7.43%
EPS(NY)19.05
Fwd EY7.51%
FCF(TTM)18.28
FCFY7.2%
OCF(TTM)19.29
OCFY7.6%
SpS56.07
BVpS11.93
TBVpS-57.58
PEG (NY)1.59
PEG (5Y)2.25
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.53% | ||
| ROE | 89.11% | ||
| ROCE | 16.21% | ||
| ROIC | 14.12% | ||
| ROICexc | 16.03% | ||
| ROICexgc | 59.12% | ||
| OM | 31.3% | ||
| PM (TTM) | 18.96% | ||
| GM | 69.71% | ||
| FCFM | 32.61% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
ROICexc(3y)15.77%
ROICexc(5y)17.27%
ROICexgc(3y)75.76%
ROICexgc(5y)77.1%
ROCE(3y)14.97%
ROCE(5y)16.28%
ROICexgc growth 3Y3.26%
ROICexgc growth 5Y-18.2%
ROICexc growth 3Y-8.67%
ROICexc growth 5Y-7.85%
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
F-Score8
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.24 | ||
| Debt/FCF | 4.94 | ||
| Debt/EBITDA | 3.25 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.72% | ||
| Profit Quality | 172.01% | ||
| Current Ratio | 1.31 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | N/A |
F-Score8
WACC9.43%
ROIC/WACC1.5
Cap/Depr(3y)24.77%
Cap/Depr(5y)23.42%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.31%
Profit Quality(3y)165.92%
Profit Quality(5y)155.23%
High Growth Momentum
Growth
EPS 1Y (TTM)17.26%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%21.13%
EPS Next Y8.45%
EPS Next 2Y5.44%
EPS Next 3Y4.87%
EPS Next 5Y4.13%
Revenue 1Y (TTM)12.88%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%9.43%
Revenue Next Year7.54%
Revenue Next 2Y4.58%
Revenue Next 3Y3.91%
Revenue Next 5Y3.12%
EBIT growth 1Y75.18%
EBIT growth 3Y1.84%
EBIT growth 5Y-0.13%
EBIT Next Year39.98%
EBIT Next 3Y10.33%
EBIT Next 5Y5.65%
FCF growth 1Y17.55%
FCF growth 3Y7.44%
FCF growth 5Y4.03%
OCF growth 1Y11.23%
OCF growth 3Y7.45%
OCF growth 5Y4.66%
AMGEN INC / 1AMGN.MI FAQ
Can you provide the ChartMill fundamental rating for AMGEN INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1AMGN.MI.
Can you provide the valuation status for AMGEN INC?
ChartMill assigns a valuation rating of 6 / 10 to AMGEN INC (1AMGN.MI). This can be considered as Fairly Valued.
How profitable is AMGEN INC (1AMGN.MI) stock?
AMGEN INC (1AMGN.MI) has a profitability rating of 7 / 10.
What is the valuation of AMGEN INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AMGEN INC (1AMGN.MI) is 13.46 and the Price/Book (PB) ratio is 21.28.
What is the financial health of AMGEN INC (1AMGN.MI) stock?
The financial health rating of AMGEN INC (1AMGN.MI) is 3 / 10.